Nature or nurture? determining the heritability of human striatal dopamine function: An [18F]-DOPA PET study

Neuropsychopharmacology

Volumn 38, Issue 3, 2013, Pages 485-491

  Stokes, Paul R A ^a,b   Shotbolt, Paul ^a   Mehta, Mitul A ^b,c   Turkheimer, Eric ^d   Benecke, Aaf ^b   Copeland, Caroline ^a   Turkheimer, Federico E ^b   Lingford Hughes, Anne R ^b   Howes, Oliver D ^a  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

18F DOPA; dopamine; environment; heritability; PET; twin

Indexed keywords

6 FLUORODOPAMINE F 18; CARBIDOPA; ENTACAPONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIZYGOTIC TWINS; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; ENVIRONMENTAL FACTOR; HERITABILITY; HUMAN; LIMBIC CORTEX; MALE; MONOZYGOTIC TWINS; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; STRIATE CORTEX;

ADULT; COHORT STUDIES; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; SOCIAL ENVIRONMENT; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84872497361     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.207     Document Type: Article

References (39)

1. Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M et al (2006). Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry 63: 1386-1395.
2. Caceres A, Hall DL, Zelaya FO, Williams SC, Mehta MA (2009). Measuring fMRI reliability with the intra-class correlation coefficient. Neuroimage 45: 758-768.
3. Cervenka S, Backman L, Cselenyi Z, Halldin C, Farde L (2008). Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. Neuroimage 40: 1287-1295.
4. Cools R, D'Esposito M (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69: e113-e125.
5. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2009). Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29: 1538-1543.
6. Cumming P, Deep P, Rousset O, Evans A, Gjedde A (1997). On the rate of decarboxylation of dopa to dopamine in living mammalian brain. Ann NY Acad Sci 835: 274-308.
7. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF (2009). Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106: 617-622.
8. Egerton A, Demjaha A, McGuire P, Mehta MA, Howes OD (2010a). The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. Neuro-image 50: 524-531.
9. Egerton A, Rees E, Bose SK, Lappin JM, Stokes PR, Turkheimer FE et al (2010b). Truth, lies or self-deception? Striatal D(2/3) receptor availability predicts individual differences in social conformity. Neuroimage 53: 777-781.
10. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009). Genetic variation in components of dopamine neuro-transmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14: 60-70.
11. Gjedde A, Kumakura Y, Cumming P, Linnet J, Moller A (2010). Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc Natl Acad Sci USA 107: 3870-3875.
12. Haber SN, Fudge JL, McFarland NR (2000). Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20: 2369-2382.
13. Haugbol S, Pinborg LH, Arfan HM, Frokjaer VM, Madsen J, Dyrby TB et al (2007). Reproducibility of 5-HT2A receptor measure-ments and sample size estimations with [18F]altanserin PET using a bolus/infusion approach. Eur J Nucl Med Mol Imaging 34: 910-915.
14. Hoshi H, Kuwabara H, Leger G, Cumming P, Guttman M, Gjedde A (1993). 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. J Cereb Blood Flow Metab 13: 57-69.
15. Howes OD, Kapur S (2009). The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 35: 549-562.
16. Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M et al (2010). Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 67: 231-239.
17. Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB et al (2011). Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: a high resolution PET study. Biol Psychol 87: 164-167.
18. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T et al (1998). Evidence for striatal dopamine release during a video game. Nature 393: 266-268.
19. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ (2009). Striatal dopamine and working memory. Cereb Cortex 19: 445-454.
20. Lappin JM, Reeves SJ, Mehta MA, Egerton A, Coulson M, Grasby PM (2009). Dopamine release in the human striatum: motor and cognitive tasks revisited. J Cereb Blood Flow Metab 29: 554-564.
21. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A et al (2007). Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164: 622-629.
22. Martinez D, Orlowska D, Narendran R, Slifstein M, Liu F, Kumar D et al (2010). Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers. Biol Psychiatry 67: 275-278.
23. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285-300.
24. McGowan S, Lawrence AD, Sales T, Quested D, Grasby P (2004). Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. Arch Gen Psychiatry 61: 134-142.
25. Meyer JH, Gunn RN, Myers R, Grasby PM (1999). Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage 9: 545-553.
26. Montgomery AJ, Thielemans K, Mehta MA, Turkheimer F, Mustafovic S, Grasby PM (2006). Correction of head movement onPET studies: comparison of methods. J Nucl Med 47: 1936-1944.
27. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O et al (2002). Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5: 169-174.
28. Pappata S, Dehaene S, Poline JB, Gregoire MC, Jobert A, Delforge J et al (2002). In vivo detection of striatal dopamine release during reward: a PET study with [(11)C]raclopride and a single dynamic scan approach. Neuroimage 16: 1015-1027.
29. Patlak CS, Blasberg RG (1985). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5: 584-590.
30. Pinborg LH, Arfan H, Haugbol S, Kyvik KO, Hjelmborg JV, Svarer C et al (2008). The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined. Neuroimage 40: 1175-1180.
31. Pruessner JC, Champagne F, Meaney MJ, Dagher A (2004). Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci 24: 2825-2831.
32. Reed T, Plassman BL, Tanner CM, Dick DM, Rinehart SA, Nichols WC (2005). Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years later. Twin Res Hum Genet 8: 362-367.
33. Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA (2005). A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 28: 216-226.
34. Reeves SJ, Mehta MA, Montgomery AJ, Amiras D, Egerton A, Howard RJ et al (2007). Striatal dopamine (D2) receptor availability predicts socially desirable responding. Neuroimage 34: 1782-1789.
35. Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH et al (2008). Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 28: 14311-14319.
36. Shotbolt P, Stokes PR, Owens SF, Toulopoulou T, Picchioni MM, Bose SK et al (2011). Striatal dopamine synthesis capacity in twins discordant for schizophrenia. Psychol Med 41: 2331-2338.
37. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M et al (2007). Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 27: 12700-12706.
38. Wahl L, Chirakal R, Firnau G, Garnett ES, Nahmias C (1994). The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain. J Cereb Blood Flow Metab 14: 664-670.
39. Willeit M, Ginovart N, Graff A, Rusjan P, Vitcu I, Houle S et al (2008). First human evidence of d-amphetamine induced displacement ofaD2/3 agonist radioligand: A [11C]- (+) -PHNO positron emission tomography study. Neuropsychopharmacology 33: 279-289.